HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusaku Amano Selected Research

Y 32885

10/2003Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
7/2003WF-536 inhibits metastatic invasion by enhancing the host cell barrier and inhibiting tumour cell motility.
1/2003Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusaku Amano Research Topics

Disease

3Neoplasms (Cancer)
12/2007 - 01/2003
3Neoplasm Metastasis (Metastasis)
10/2003 - 01/2003
1Breast Neoplasms (Breast Cancer)
12/2007
1Melanoma (Melanoma, Malignant)
10/2003
1Experimental Melanoma
10/2003
1Body Weight (Weight, Body)
10/2003
1Fibrosarcoma
07/2003
1Lewis Lung Carcinoma
01/2003

Drug/Important Bio-Agent (IBA)

3Y 32885IBA
10/2003 - 01/2003
2Protein Kinases (Protein Kinase)IBA
10/2003 - 01/2003
2matrigelIBA
10/2003 - 01/2003
2benzamideIBA
07/2003 - 01/2003
1ErbB Receptors (EGF Receptor)IBA
12/2007
1MP 412IBA
12/2007
1Gefitinib (Iressa)FDA Link
12/2007
1Pharmaceutical PreparationsIBA
10/2003
1Antineoplastic Agents (Antineoplastics)IBA
10/2003
1Paclitaxel (Taxol)FDA LinkGeneric
10/2003
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2003

Therapy/Procedure

1Oral Administration
10/2003
1Subcutaneous Injections
10/2003